v3.26.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total Revenues $ 95,203 $ 16,961 $ 147,147 $ 32,585
Costs and Expenses        
Costs of revenue 160,795 28,608 231,532 52,723
Research, development and manufacturing operations 697,297 622,921 1,391,525 1,174,593
Selling, general and administrative 1,072,058 1,032,825 2,512,525 1,990,676
Share-based compensation 89,605 404,219 177,091 615,726
Depreciation and amortization 20,950 17,442 42,427 34,352
Total Costs and Expenses 2,040,705 2,106,015 4,355,100 3,868,070
Loss from Operations (1,945,502) (2,089,054) (4,207,953) (3,835,485)
Other Income/(Expense)        
Other income/(expense), net 130,517 37,395 229,457 124,781
Interest expense (12,159) (12,159) (24,184) (27,410)
Total Other Income/(Expense) 118,358 25,236 205,273 97,371
Income/(Loss) on Equity Method Investments 560 (1,579) (1,066) (1,579)
Net Income/(Loss) (1,826,584) (2,065,397) (4,003,746) (3,739,693)
Less: Series 1C preferred stock dividends (20,203) (49,159) (40,632) (102,227)
Net Income/(Loss) Available to Common Shareholders $ (1,846,787) $ (2,114,556) $ (4,044,378) $ (3,841,920)
Net Income/(Loss) Per Share (Basic) $ (0.19) $ (1.17) $ (0.46) $ (2.33)
Net Income/(Loss) Per Share (Diluted) $ (0.19) $ (1.17) $ (0.46) $ (2.33)
Weighted Average Common Shares Outstanding (Basic) 9,587,205 1,802,501 8,782,811 1,645,767
Weighted Average Common Shares Outstanding (Diluted) 9,587,205 1,802,501 8,782,811 1,645,767
Other Comprehensive Income/(Loss)        
Foreign currency translation gain/(loss) $ (244) $ 5,334 $ (1,915) $ 7,832
Net Comprehensive Income/(Loss) (1,826,828) (2,060,063) (4,005,661) (3,731,861)
Products        
Total Revenues $ 95,203 $ 16,961 124,147 $ 32,585
Milestone and engineering        
Total Revenues     $ 23,000